Key facts
- This page summarizes Panagiotis Tsourapas's Form 4 filing for COLGATE PALMOLIVE CO (CL).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 13 Feb 2026, 16:25.
Panagiotis Tsourapas - 11 Feb 2026 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)
- Reporting relationship
- COO, Eur., APac, Afr Eur, Skin
- Issuer ticker
- CL
- Reported as of
- 11 Feb 2026
- Net transaction value
- -$957,936
- SEC form
- 4
- Accepted by SEC
- 13 Feb 2026, 16:25:19 UTC
- Prior SEC filing
- 05 Dec 2025
- Next SEC filing
- 25 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kristine Hutchinson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Panagiotis Tsourapas filed Form 4 for COLGATE PALMOLIVE CO (CL) on 13 Feb 2026.
Change
- Previous filing in this sequence was filed on 05 Dec 2025.
- Current net transaction value: -$957,936.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001576945
Primary reporting owner
Tsourapas Panagiotis
- Relationship
- COO, Eur., APac, Afr Eur, Skin
- Address
- C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE, NEW YORK
- Signature
- /s/ Kristine Hutchinson, Attorney-in-Fact
- Signature date
- 13 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CL
transaction
Common Stock
Options Exercise
- Transaction value
- $2,674,350
- Shares
- +35,000
- Change %
- +336%
- Price
- $76.41
- Shares after
- 45,415
- Date
- 11 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
CL
transaction
Common Stock
Sale
- Transaction value
- $3,311,326
- Shares
- -35,000
- Change %
- -77%
- Price
- $94.61
- Shares after
- 10,415
- Date
- 11 Feb 2026
- Ownership
- Direct
- Footnotes
- F2, F3
CL
transaction
Common Stock
Options Exercise
- Transaction value
- $1,146,150
- Shares
- +15,000
- Change %
- +144%
- Price
- $76.41
- Shares after
- 25,415
- Date
- 12 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
CL
transaction
Common Stock
Sale
- Transaction value
- $1,467,111
- Shares
- -15,000
- Change %
- -59%
- Price
- $97.81
- Shares after
- 10,415
- Date
- 12 Feb 2026
- Ownership
- Direct
- Footnotes
- F2, F4
CL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,568
- Date
- 11 Feb 2026
- Ownership
- By Issuer's 401(k) Plan Trustee
CL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 60,745
- Date
- 11 Feb 2026
- Ownership
- By Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CL
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -35,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 34,938
- Date
- 11 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,000
- Exercise price
- $76.41
- Footnotes
- F1, F5
CL
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -15,000
- Change %
- -43%
- Price
- $0.000000
- Shares after
- 19,938
- Date
- 12 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $76.41
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Exercise of stock options awarded under the issuer's incentive compensation plan.
Footnote F2
Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
Footnote F3
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.50 to $94.78 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $97.74 to $97.89 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.